↓ Skip to main content

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Overview of attention for article published in Journal of Hematology & Oncology, December 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
15 X users
patent
1 patent

Citations

dimensions_citation
400 Dimensions

Readers on

mendeley
245 Mendeley